or Try an Advanced Search...

    ETF Components for FLHK - Franklin FTSE Hong Kong ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    BGNE D 0.15 1.40

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Bruton's Tyrosine Kinase Cancer Lymphoma Monoclonal Antibodies Monoclonal Antibody Oncogenes Protein Kinase Ras Subfamily Rp1
    Industries: Biotechnology

    Recent News for Franklin FTSE Hong Kong ETF & its Holdings

    Date Stock Title
    May 1 BGNE BeiGene, AbbVie patent spat to get trial from USPTO appeals board
    Apr 28 BGNE Tracking Last Week's Top Performers: Are These 15 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
    The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of FTSE Hong Kong RIC Capped Index (the FTSE Hong Kong Capped Index). Under normal market conditions, the fund invests at least 80% of its assets in the component securities of the FTSE Hong Kong Capped Index and in depositary receipts representing such securities. The FTSE Hong Kong Capped Index is based on the FTSE Hong Kong Index and is designed to measure the performance of Hong Kong large- and mid-capitalization stocks. The fund is non-diversified.
    Exchange Traded Fund ETF Stock Market Index Ftse 100 Index Ftse Group
    Back to the Main FLHK Page...